Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 6
1 April 2002
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

Articles

Cyclotides: A Novel Type of Cytotoxic Agents
Petra Lindholm; Ulf Göransson; Senia Johansson; Per Claeson; Joachim Gullbo; Rolf Larsson; Lars Bohlin; Anders Backlund
View articletitled, Cyclotides: A Novel Type of Cytotoxic Agents
Open the PDF for in another window
Pretreatment Deoxycytidine Kinase Levels Predict in Vivo Gemcitabine Sensitivity1
Judith R. Kroep; Willem J. P. Loves; Clasina L. van der Wilt; Enrique Alvarez; Iannis Talianidis; Epie Boven; Boudewijn J. M. Braakhuis; Cornelis J. van Groeningen; Herbert M. Pinedo; Godefridus J. Peters
View articletitled, Pretreatment Deoxycytidine Kinase Levels Predict <em>in Vivo</em> Gemcitabine Sensitivity<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Inhibition of Cell Growth by NB1011 Requires High Thymidylate Synthase Levels and Correlates with p53, p21, Bax, and GADD45 Induction
Saskia T. C. Neuteboom; Patricia L. Karjian; Christopher R. Boyer; Malgorzhata Beryt; Mark Pegram; Geoffrey M. Wahl; H. Michael Shepard
View articletitled, Inhibition of Cell Growth by NB1011 Requires High Thymidylate Synthase Levels and Correlates with p53, p21, Bax, and GADD45 Induction
Open the PDF for in another window
Transcriptional Repression of ErbB2 by Histone Deacetylase Inhibitors Detected by a Genomically Integrated ErbB2 Promoter-reporting Cell Screen1
Gary K. Scott; Chloe Marden; Fan Xu; Liana Kirk; Christopher C. Benz
View articletitled, Transcriptional Repression of ErbB2 by Histone Deacetylase Inhibitors Detected by a Genomically Integrated ErbB2 Promoter-reporting Cell Screen<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
CP248, a Derivative of Exisulind, Causes Growth Inhibition, Mitotic Arrest, and Abnormalities in Microtubule Polymerization in Glioma Cells1
Jung-Taek Yoon; Alexander F. Palazzo; Danhua Xiao; Thomas M. Delohery; Peter E. Warburton; Jeffrey N. Bruce; W. Joseph Thompson; Gerhard Sperl; Clark Whitehead; John Fetter; Rifat Pamukcu; Gregg G. Gundersen; I. Bernard Weinstein
View articletitled, CP248, a Derivative of Exisulind, Causes Growth Inhibition, Mitotic Arrest, and Abnormalities in Microtubule Polymerization in Glioma Cells<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Coordinate Late Expression of Trefoil Peptide Genes (pS2/TFF1 and ITF/TFF3) in Human Breast, Colon, and Gastric Tumor Cells Exposed to X-Rays1
Elizabeth K. Balcer-Kubiczek; George H. Harrison; Jing-Fan Xu; Peter L. Gutierrez
View articletitled, Coordinate Late Expression of Trefoil Peptide Genes (<em>pS2/TFF1</em> and <em>ITF/TFF3</em>) in Human Breast, Colon, and Gastric Tumor Cells Exposed to X-Rays<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin C1
John D. Allen; Arnold van Loevezijn; Jeany M. Lakhai; Martin van der Valk; Olaf van Tellingen; Glen Reid; Jan H. M. Schellens; Gerrit-Jan Koomen; Alfred H. Schinkel
View articletitled, Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter <em>in Vitro</em> and in Mouse Intestine by a Novel Analogue of Fumitremorgin C<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window

Minireviews

Multidrug Resistance and Pharmacological Protection Mediated by the Breast Cancer Resistance Protein (BCRP/ABCG2)1
John D. Allen; Alfred H. Schinkel
View articletitled, Multidrug Resistance and Pharmacological Protection Mediated by the Breast Cancer Resistance Protein (BCRP/ABCG2)<sup><a href="javascript:;" reveal-id="FN1" data-open="FN1" class="link link-ref link-reveal xref-fn js-xref-fn split-view-modal">1</a></sup>
Open the PDF for in another window
Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy
Mack N. Barnes; Candace J. Coolidge; Akseli Hemminki; Ronald D. Alvarez; David T. Curiel
View articletitled, Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy
Open the PDF for in another window

Advertisement

Breaking
Ribociclib Plus AI Greenlighted for High-Risk Breast Cancer
AACR Releases 14th Annual Cancer Progress Report
Mesothelioma Newest Approved Indication for Pembrolizumab
View more recent articles
Latest News
AMG 193 Safe, Effective in Multiple Cancer Types
STING Immune Pathway Discovery Earns Lasker Prize
Assessing New RAF-Directed Drugs in Melanoma
View more recent articles
Research Watch
The Dynamics of Ductal Tree Remodeling Shape Mammary Field Cancerization
An Age-Associated Increase in Myelopoiesis Promotes Lung Cancer Development
Post-Fast Refeeding Drives Stem Cell Regeneration via Polyamine Metabolism
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept